Durbin Strikes Back

After we defeated his anti-supplement bill in 2022, Senator Dick Durbin (D-IL) is trying to do the same thing again. Let’s make sure he doesn’t succeed.

It’s time, once again, to defend our supplement access in the face of an FDA / Big Pharma / Sen. Durbin onslaught. We’ve done it before, and we can do it again—but not without a powerful grassroots response telling Congress NOT to restrict our supplements.

MPL on the move

Earlier this week, Sen. Durbin, a longtime supplement opponent, reportedly sent letters to several supplement industry trade groups indicating he would be reintroducing his Dietary Supplement Listing Act requiring mandatory product listing (MPL) for supplements. This comes on the heels of the FDA asking for the authority to require MPL in its list of legislative proposals for Fiscal Year 2025, as it did the previous year. With your help and support, we defeated Sen. Durbin’s legislation in 2022, and we can do so again.  But, like last time, we need your help.

MPL seeks to create a registry of all supplements on the market bringing it ever closer to the Canadian model that our colleagues at the Natural Health Products Protection Association have confirmed are wiping more and more products from Canadian retail shelves. Sen. Durbin and the FDA claim this policy would help regulators “know when new products are introduced and quickly identify dangerous or illegal products on the market.” We believe Sen. Durbin and the FDA are using safety as a smokescreen and that such a registry will be used to target and eliminate products that the agency believes do not comply with its ridiculous regulations. Just like in Canada.